Trial Profile
Randomized open-label trial to evaluate the efficacy of artesunate-amodiaquin for seasonal malaria chemoprevention in suburban school of Bamako, Sirakoro-Meguetana, Mali
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Artesunate/amodiaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- 08 Jan 2018 Status changed from active, no longer recruiting to completed.
- 16 Sep 2016 New trial record